Stock Price

The insurer's double-digit dividend hike follows a year of record core earnings, rewarding shareholders and showcasing its robust financial health.

The satellite firm unveils a complex debt shuffle and $1B capital raise, fueling its network vision while sending its stock tumbling on dilution fears.

Grid Dynamics' new 'Preferred Vendor' status with a top cloud provider validates its role in solving the complex engineering challenges of enterprise AI.

With a strong cash position, Arcus Biosciences heads into a pivotal year as investors await critical data on its promising cancer and autoimmune pipeline.

Indoor ag firm Local Bounti faces a potential NYSE delisting for the second time, highlighting severe financial pressures in the high-tech farming sector.

Lincoln International data reveals slowing growth and rising debt distress in private companies, a stark contrast to the heated M&A market for top assets.

The energy giant's dividend increase to $1.27 reflects robust financial health, strategic pivots to renewables, and a strong commitment to shareholders.

A massive $313M federal funding win brings hope to the ALS community, pushing total investment past $1.6B. But how close are we to a real breakthrough?

With its Q4 and full-year 2025 earnings release imminent, Ingevity faces investor scrutiny over its recent strategic divestitures and market position.

Publicly traded SUI Group launches its Ethena-backed synthetic dollar and a new yield vault, aiming to lure institutional capital to the Sui blockchain.

A shipping firm's subsidiary is using complex crypto strategies to fund an ambitious AI roadmap, signaling a new era for corporate treasury management.

For the seventh year, General Mills is one of America's most responsible companies. We explore the data, public trust, and strategy behind this major ESG achievement.

With triple-digit growth, the firm's partner-led model is dominating the market as companies race to defend against escalating third-party cyber threats.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

At a key summit, Candel Therapeutics will showcase how its oncolytic virus, CAN-3110, uses biomarkers to fight one of the deadliest brain cancers.

As a wave of old solar panels looms, Comstock Inc. is betting on a certified zero-landfill recycling facility. Can this green venture save its financials?

Rapid7's 2026 awards reveal a shift in cybersecurity, where partners are no longer just resellers but crucial allies in the global, AI-driven fight.

Insight Molecular Diagnostics secures $26M to expand its transplant rejection test to the heart market, backed by a major shareholder amid market dilution concerns.

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.